Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:33 PM
Ignite Modification Date:
2025-12-24 @ 4:33 PM
NCT ID:
NCT00420966
Eligibility Criteria:
Inclusion Criteria:
* All children who receive at least one dose of palivizumab
Exclusion Criteria:
* The child's parent or legal guardian could not communicate in either English or French
* The child had received palivizumab as part of a clinical trial during the study period
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00420966
Study Brief:
Protocol Section:
NCT00420966